Recruiting RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study NCT07030569 Conditions Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +18 more Locations Fondazione IRCCS Istituto Nazionale Tumori — Milan, Italy View Trial Details
Recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812 Conditions Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more Locations Centro di Riferimento Oncologico IRCCS — Aviano, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili — Brescia, Italy Humanitas Istituto Clinico Catanese — Catania, Italy ASST Lariana - Ospedale Sant'Anna — Como, Italy View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid NCT00172029 Conditions Breast Cancer With Metastatic Bone Disease, Breast Diseases, Breast Neoplasms, +4 more Locations Novartis Investigative Site — Ankara, Turkey (Türkiye) Novartis Investigative Site — Antalya, Turkey (Türkiye) Novartis Investigative Site — Bursa, Turkey (Türkiye) Novartis Investigative Site — Istanbul, Turkey (Türkiye) View more locations Show fewer locations Loading locations... View Trial Details
